Advances in Substance Use Disorder Treatment, Volume 178 in the International Review in Neurobiology series, presents a comprehensive exploration of emerging therapies and approaches in the field. Topics in this new release include Introduction: Current Treatments, Oxytocin and Vasopressin, Neuroactive steroids, Pharmacological activators of ALDH2, Anti inflammatories and mesenchymal stem cells, Sodium oxybate, Psychedelic compounds, Cannabinoids, Environmental Enrichment, Animal models and translational challenges, GABAergic compounds, and Ghrelin system and GLP-1. Explores neurobiological, pharmacological, and unconventional modalities for treating AUDIntegrates insights from leading experts, bridging pre-clinical and clinical viewpointsInvestigates new compounds and cutting-edge research in AUD treatment INDICE: 1. Introduction: Current TreatmentsRosana Camarini and Fabio Cardoso Cruz2. Oxytocin and VasopressinHoward C. Becker, Sutton Scarboro and Marcelo Lopez3. Neuroactive steroidsLeslie Morrow4. Pharmacological activators of ALDH2Mario Rivera5. Anti inflammatories and mesenchymal stem cellsFernando Ezquer, Javiera Gallardo and Pablo Berríos-Cárcamo6. Sodium oxybateJulien Guiraud7. Psychedelic compoundsEduardo Ary Villela Marinho Sr.8. CannabinoidsCristiane R. Carvalho9. Environmental EnrichmentRosana Camarini, Paola Palombo and Regina Noto10. Animal models and translational challengesFabio Cardoso Cruz11. GABAergic compoundsLais F. Berro12. Ghrelin system and GLP-1Elisabet Jerlhag Holm
- ISBN: 978-0-443-29638-3
- Editorial: Academic Press
- Encuadernacion: Cartoné
- Páginas: 322
- Fecha Publicación: 01/11/2024
- Nº Volúmenes: 1
- Idioma: Inglés